BMC Cardiovascular Disorders · 2020 · 46 citations · 18 references
MedicineCardiologyInternal MedicineClinical CardiologyInterventional CardiologyPreventive CardiologyCardiovascular DiseaseCoronary AngiographyCoronary Artery DiseaseIschemic Heart DiseasePercutaneous Coronary InterventionStent PlacementCoronary Heart Disease EpidemiologyCoronary Stent RestenosisCoronary StentingRestenosis After StentingRisk Factor Evaluation
BACKGROUND: Percutaneous coronary intervention (PCI) is a common treatment for patients with coronary heart disease, and intra-stent restenosis (ISR) is a serious complication after PCI. It's necessary to identify the potential risk factors to provide evidence for the prevention of ISR. METHODS: The patients who underwent coronary angiography 1 year after PCI in our hospital from January 2017 to May 2019 were selected. The characteristics and results of clinical examination of ISR and no-ISR patients were compared, Multivariate logistic regression analyses were performed to identify the risk factors. RESULTS: A total of 209 patients were included, the incidence of ISR after PCI was 30.62%. There were significant differences on the hypertension, diabetes, number of coronary artery lesions, reasons for stent implantation, the diameter of stent, the length of stent and stent position between ISR group and no-ISR patients (all p < 0.05). The LDL-C in ISR groups was significantly higher than that of no-ISR group (p = 0.048), there were no significant differences between two groups in FPG, TG, TC, HDL-C, Apo A1, Apo B, LP-a and glycated haemoglobin (all p > 0.05). The hypertension (OR 4.30, 95% CI 1.12-9.34), diabetes (OR 5.29, 95% CI 1.25-9.01), number of coronary artery lesions ≥ 2 (OR 4.84, 95% CI 1.21-9.55), LDL-C ≥ 1.9 mmol/L (OR 5.93, 95% CI 2.29-10.01), unstable angina (OR 2.92, 95% CI 1.20-4.55), left anterior descending artery (OR 4.01, 95% CI 1.73-7.58), diameter of stent ≥ 3 mm (OR 5.42, 95% CI 1.24-10.84), the length of stent > 20 mm (OR 3.06, 95% CI 1.19-5.22) were the independent risk factor for ISR (all p < 0.05). CONCLUSION: It is necessary to take preventive measures against these risk factors to reduce ISR, and studies with larger sample size and longer follow-up on this issue are needed in the future.
18
John H. Alexander, Daniel Wojdyla, Amit N. Vora et al. · Circulation · 2020 · 130 citations · Full text
Zhixiong Zhong, Jingyuan Hou, Qi-Feng Zhang et al. · Lipids in Health and Disease · 2019 · 73 citations · Full text
Fernándo Alfonso, Marı́a José Pérez-Vizcayno, Bruno García del Blanco et al. · JACC: Cardiovascular Interventions · 2016 · 66 citations · Full text
Medicine, Cardiology, Surgery +14
Fernándo Alfonso, Ángel Cequier, Juan Ángel et al. · American Heart Journal · 2006 · 54 citations